AI Terminal
FORTERRA PLC
Board/Management Information • Feb 1, 2023
5334_dirs_2023-02-01_e8b74b69-1b04-45a7-bcc5-0e7143b131cb.html
Board/Management Information
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 5640O
Forterra plc
01 February 2023
1 February 2023
Forterra plc
Director Declaration
Pursuant to Listing Rule 9.6.14(2) Forterra plc (the "Company") announces that Martin Sutherland, a Non-Executive of the Company, with effect from 1 February 2023 has been appointed as a Non-Executive Director of Alliance Pharma plc, a company listed on the London Stock Exchange AIM market.
Enquiries:
| Forterra plc | +44 (0) 1604 707 600 |
| Ashley Thompson (Company Secretary) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RDNNKDBDFBKKABK